David López García is a biologist holding an executive position in the healthcare industry, with a broad career in various business fields. Following his teaching and research work at the UNAM, he ventured into areas such as health insurance risk selection and clinical diagnostics, handling the commercialization and strategies for highly specialized tests like autoimmunity, tumor markers, and plasma proteins. Since 1997, he has fully integrated into the pharmaceutical industry, leading commercial excellence teams in areas such as Oncology, Transplants, and Neurology. For the past 20 years, he has focused on directing business and specialized companies in Rare Diseases. His experience has enabled him to lead the launches of companies, commercial teams, and products in various countries across the Mexico Region, Central America, and Andean countries, all focused on offering the most cutting-edge therapeutic solutions and thereby improving the quality of life for patients, who are the main reason for his inspiration.
David López García: Leader in the Pharmaceutical Industry and Rare Diseases
Biologist David López García is an experienced healthcare executive with a 20-year career in pharma. He has led teams in oncology, neurology, and specialized rare disease companies, launching cutting-edge therapeutic solutions to improve patient quality of life in Mexico and Latin America.
